SynthesisNeurosurgical review2026
Symptom duration and postoperative outcomes in degenerative cervical myelopathy: a systematic review and meta-analysis.
Synthesis in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSurgical decompression is regarded as standard treatment for degenerative cervical myelopathy (DCM). However, the timing of surgery remains a critical yet unresolved issue in clinical practice. Therefore, this meta-analysis aimed to evaluate the impact of symptom duration on surgical outcomes and determine the optimal timing for surgery.
methodsA systematic search was conducted on 16th November 2025 using PubMed, Ovid, Scopus, and Web of Science databases to identify eligible articles. Studies comprising patients with DCM undergoing surgery, assessing outcome by mJOA score at a minimum of 12 months of follow-up, were included. A risk of bias in the included studies was assessed using the Quality in Prognostic Studies (QUIPS) tool.
resultsFrom 1522 records, 14 studies encompassing a total of 3162 patients were included in the current meta-analysis. Symptom duration was significantly associated with postoperative mJOA score according to univariate (OR: 2.15; 95% CI: 1.64-2.81) and multivariate data (OR: 1.78; 95% CI: 1.23-2.57). Meta-regression showed that neither baseline mJOA score nor age affected the association. Moreover, early surgery resulted in reduced neck pain and disability measured by the NDI score (OR: 1.56; 95% CI: 1.24-1.95), but not quality of life according to EQ-5D (OR: 1.47; 95% CI: 0.74-2.89). At the 6-month and 12-month cut-off points, patients with longer symptom duration had significantly worse outcomes in terms of mJOA score, and after exclusion of high-risk-of-bias studies, only at the 12-month cut-off point. However, the test for subgroup differences was insignificant (p = 0.89).
conclusionLonger symptom duration is associated with poor surgical outcomes. Therefore, the duration of symptoms should be regarded as a clinically meaningful factor when counseling patients with DCM and planning surgical intervention. An optimal threshold for symptom duration, indicating when the surgery should be performed to prevent poor outcomes, cannot be recommended due to limitations of published data and needs to be established by further well-designed prospective studies. Future research should also aim to define optimal time cut-offs across different degrees of DCM severity and varied disease trajectories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.